~ BioMedInnovation Aims to Address Global Shortages of Life-Saving Machines Due to COVID-19 via Manufacturing Process Independent of Commercial and Other Ventilator Supply Chains
~~ Collaborations with Several Motor Sports Manufacturing Teams Allows for Immediate Assembly of Up to 1,000 Ventilator Machines Per Week
~~ BioMedInnovation's Back-Pressure
Regulator (BPR) Based Ventilator Technology, Which Can be Used
in Mobile Settings, Prevents Against High Pressures that Could
Damage the Lung
"BMI is pleased with the FDA's decision, which underscores the applicability of the core technology in our organ perfusion system. In partnership with Lawrence Livermore National Laboratory, we were able to quickly design a machine with minimal components that is easy to assemble in an effort to help COVID-19 patients and healthcare providers who are in need of highly efficient, value-added ventilators," said Sherif Gabriel, chief executive officer of BioMedInnovations LLC.
Full Press Release:
"This effort has been truly collaborative, and we are honored to have partners such as Roush Yates Manufacturing Solutions ready to quickly manufacture as many as 1,000 of these potentially life-saving machines per week," said Carrie DiMarzio, chief operations officer of BioMedInnovations LLC.
CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential